Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Achmea Investment Management B.V. raised its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3,322.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,986 shares of the medical research company’s stock after acquiring an additional 10,665 shares during the […]
Victory Capital Management Inc. lifted its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 537.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 126,755 shares of the medical research company’s stock after acquiring an additional 106,872 shares during the period. […]
Exact Sciences (NASDAQ:EXAS – Get Free Report) released its earnings results on Tuesday. The medical research company reported ($0.45) EPS for the quarter, topping analysts’ consensus estimates of ($0.50) by $0.05, Briefing.com reports. The company had revenue of $622.10 million during the quarter, compared to analysts’ expectations of $601.14 million. Exact Sciences had a negative […]
AtonRa Partners decreased its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 12.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,530 shares of the medical research company’s stock after selling 1,622 shares during the […]
AtonRa Partners reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 12.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,530 shares of the medical research company’s stock after selling 1,622 shares during the quarter. […]